These breakthroughs and the need for additional research into hundreds of other diseases is why this committee fought to increase funding for the NIH by $2,000,000,000 in the fiscal year 2016 omnibus spending bill.
Lowey discusses the committee's efforts to boost NIH funding for research.
Share & report
More from Nita Lowey
I am not going to vote for a bill that comes before me that does not include the poor working people that I represent.
If FDA does not publicly list the products that applied, how can State and Federal enforcement agencies know whether a product can legally remain for sale?
Other voices in this conversation
